Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile
Table 5
Haplotype frequencies and comparison between colonic Crohn’s patients with L2 and L3 location, responders and nonresponders to infliximab therapy, in the chromosomal regions including: (a) S100A9 and S100A8 genes (rs11205276, rs3014866, rs724781, and rs3006488); (b) G0S2 gene (rs4844486, rs1473683); (c) TNFAIP6 gene (rs11677200, rs2342910, rs3755480, and rs10432475); and (d) IL11 gene (rs1126760, rs1042506).